CIMTCIMT and NDT for Stroke Upper Extremity Rehabilitation
This study aims to evaluate the effectiveness of Constraint-Induced Movement Therapy and Neuro-Developmental Treatment in improving upper arm and hand function in stroke patients.
Constraint-induced movement therapy
+ Neurodevelopmental Treatment
Ischemic Stroke+6
+ Thrombotic Stroke
+ Brain Diseases
Treatment Study
Summary
Study start date: June 28, 2024
Actual date on which the first participant was enrolled.The study is focused on comparing two different rehabilitation methods, CIMT (Constraint-Induced Movement Therapy) and NDT (Neurodevelopmental Treatment), to help stroke patients regain function in their arms and hands. By adding these techniques to regular physiotherapy, the research aims to find the most effective way to improve movement and strength in the upper body. This is important because better rehabilitation strategies can significantly impact the recovery and quality of life for those who have suffered a stroke, allowing them to perform daily activities more independently. Participants in this study will undergo sessions involving CIMT or NDT alongside standard physiotherapy exercises. CIMT involves using the affected limb more actively by restricting the use of the unaffected limb, while NDT focuses on improving movement patterns and muscle control through guided exercises. Researchers will evaluate the progress of participants by measuring improvements in their arm and hand functions. The study seeks to determine which method offers better results, ultimately guiding therapists in choosing the best approach to help stroke survivors recover more efficiently.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.10 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 40 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Group II
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location